Curis Profit Margin

The latest profit margin for CRIS is -3.0% as of March 2026. That compares with -3.76% in the prior-year period — up 20.3% year over year. That is below the Healthcare sector average of 15.58%. Investors often review this figure alongside Curis's historical trend and sector peers before judging valuation or financial health.

Over the past year, CRIS's profit margin moved from -3.76% to -3.0% — a 20.3% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Curis's valuation or profitability profile.

Against Healthcare companies, CRIS currently prints -3.0% for profit margin, while the sector average sits near 15.58%. That is roughly 2022.9% below the sector mean. Large gaps often invite a closer look at Curis's growth, margins, and balance sheet.

Profit Margin shows how effectively Curis converts resources into returns. At -3.0%, CRIS may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -3.76% in the prior-year period — up 20.3% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting CRIS's profit margin (-3.0%), review year-over-year change from -3.76%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.